ANDREW N SCHIFF
CIK 1172252 · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.99M
Companies
9
Total Filings
43
Lifetime Open-Market Net
$8.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 459,995 | $4.32 | $1.99M | -$1.15M | 19 | 2026-06-08 |
| GLUE | Director | — | $18.23 | — | $0 | 5 | 2025-06-16 |
| Elevation Oncology, Inc. (ELEV) Delisted | — | $0.36 | — | $0 | 1 | 2021-06-28 | |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 2,718,226 | $0.56 | $1.52M | $0 | 2 | 2019-12-06 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 10,100,000 | $18.62 | $188.06M | $7.50M | 1 | 2019-07-15 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | -$35.35M | 11 | 2017-05-01 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | — | $1.51 | — | $0 | 1 | 2015-06-10 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 3,452,493 | — | — | $37.59M | 1 | 2014-08-06 |
| INTERPHARM HOLDINGS INC (IPA) Delisted | 10%+ Owner | — | $2.07 | — | $0 | 1 | 2008-03-03 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-19 | ACRS | Sell (S) | −52,037 | -$862.1K | EDGAR |
| 2022-10-11 | ACRS | Sell (S) | −7,324 | -$118.3K | EDGAR |
| 2022-10-06 | ACRS | Sell (S) | −45,539 | -$749.0K | EDGAR |
| 2022-06-21 | ACRS | Sell (S) | −19,565 | -$296.3K | EDGAR |
| 2022-06-16 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | ACRS | Mixed | +3,356 | $0 | EDGAR |
| 2021-06-28 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-25 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | ACRS | Mixed | +7,333 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.